| Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases. | |
| | |
MedLine Citation:
|
PMID: 20959879 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Left atrial (LA) systolic force (LASF) is significantly increased in chronic heart failure (CHF), arterial hypertension (HT) and aortic stenosis (AS). The increase is proportional to the degree of left ventricular hypertrophy and diastolic dysfunction. OBJECTIVES: To assess the magnitude of changes in maximal LA volume (LAV(max)) and LASF in systolic CHF compared with other cardiac diseases, and to assess whether the left atrium remodels differently and works in response to specific conditions affecting diastolic function and to individual factors associated with LA alterations. METHODS: LAV(max) and LASF were measured and evaluated by two-dimensional Doppler echocardiography in 94 patients with systolic CHF and normal left ventricular filling pressure, 100 control patients, 181 patients with HT, 40 patients with idiopathic hypertrophic cardiomyopathy (HCMP) and 85 patients with AS. The prevalence of LA dilation and supernormal LASF (defined as values of LAV(max) and LASF exceeding two SDs of the mean of controls) was measured in all groups. RESULTS: LAV(max) and LASF were 7.1±2 mL/m(3) and 7.8±4 kdynes in controls, and 11.0±4 mL/m(3) and 19.7±11 kdynes in systolic CHF patients, respectively (both P<0.001). These values were significantly higher than in patients with HT, but similar to those with AS and HCMP. LA dilation and supernormal LASF were detected in 13% and 11% of patients with HT, 32% and 59% of patients with AS, 26% and 43% of patients with HCMP, and 41% and 56% of patients with systolic CHF, respectively (all P<0.01). In multiple logistic analysis, systolic CHF represented the strongest predictor of supernormal LASF. It was not independently associated with LA dilation, which was mainly related to indexes of volume load. CONCLUSIONS: LAV(max) and LASF were markedly increased in patients with systolic CHF, with a magnitude that was significantly higher than that of HT patients, but similar to that measured in HCMP and AS patients. In the present community population with various cardiac diseases, systolic CHF represented the most powerful stimulus for increasing LASF and was not related to LA dilation. |
| | |
Authors:
|
Giovanni Cioffi; Eva Gerdts; Dana Cramariuc; Luigi Tarantini; Andrea Di Lenarda; Giovanni Pulignano; Donatella Del Sindaco; Carlo Stefenelli; Giovanni de Simone |
Related Documents
:
|
17854389 - High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients ... 2209649 - Quantitation of left ventricular asynchrony on radionuclide angiography phase images. 11315119 - Factor v leiden and its relation to left ventricular thrombus in acute myocardial infar... 10146449 - Reliability of doppler color flow mapping in the identification and localization of mul... 10962749 - Efficacy of single lead vdd pacing in patients with impaired and normal left ventricula... 3948349 - Respiratory system impedance in patients with acute left ventricular failure: pathophys... 18759599 - The natural history of the chiari type i anomaly. 10329809 - A comparison of skin prick tests, intradermal skin tests, and rasts in the diagnosis of... 17906379 - Impairment of flow-mediated vasodilatation of brachial artery in patients with cushing'... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Experimental and clinical cardiology Volume: 15 ISSN: 1918-1515 ISO Abbreviation: Exp Clin Cardiol Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-10-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9715903 Medline TA: Exp Clin Cardiol Country: Canada |
Other Details:
|
Languages: eng Pagination: e45-51 Citation Subset: - |
Affiliation:
|
Department of Cardiology, Villa Bianca Hospital, Trento, Italy; |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration.
Next Document: Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 an...